Abstract
The purpose of the review was to systematize the available data on the epidemiology and diagnosis of the metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS). The information search was conducted using Internet resources (PubMed, EMBASE, Google Scholar, E-Library) and literature sources for the years 2000-2020. The modern studies indicate that the prevalence of metabolic disorders varies in groups of women with different PCOS phenotypes. Numerous risk factors in PCOS lead to a significant increase in risk for cardiovascular diseases. Patients with PCOS diagnosed according to AE-PCOS Society criteria have the most severe metabolic features and risk of cardiovascular disease. Hyperandrogenism in PCOS is closely related to the aggravation of abdominal obesity, and together with insulin resistance forms the metabolic core for the development of cardiovascular diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
